Evidence map›Paper›PMID 33529319›Full record

ArticleBlood2021

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism.

Vincent Ten Cate, Jürgen H Prochaska, Andreas Schulz, Thomas Koeck, Alejandro Pallares Robles, Michael Lenz, Lisa Eggebrecht, Steffen Rapp, Marina Panova-Noeva, H Ardeschir Ghofrani and 14 more

Open access · bronzeAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Blood, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Proteomic Insights into Venous Thromboembolism.Medical sciences (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Proteomics in thrombosis research.Research and practice in thrombosis and haemostasis · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Vincent Ten CatePreventive Cardiology and Preventive Medicine, Center for Cardiology.
Jürgen H ProchaskaPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Andreas SchulzPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Thomas KoeckPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Alejandro Pallares RoblesCenter for Thrombosis and Hemostasis (CTH), and.
Michael LenzPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Lisa EggebrechtPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Steffen RappPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Marina Panova-NoevaPreventive Cardiology and Preventive Medicine, Center for Cardiology.
H Ardeschir GhofraniUniversity Hospital Gießen and Marburg, Ambulance for Pulmonary Hypertension, Gießen, Germany.ORCID 0000-0002-2029-4419
F Joachim MeyerLung Center Munich, Department of Pneumology and Pneumological Oncology, München Klinik Bogenhausen, München, Germany.
Christine Espinola-KleinDepartment of Angiology.
Karl J LacknerInstitute of Clinical Chemistry and Laboratory Medicine.
Matthias MichalDepartment of Psychosomatic Medicine and Psychotherapy.
Alexander K SchusterDepartment of Ophthalmology, and.
Konstantin StrauchInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Alexander M ZinkBayer AG, Wuppertal, Germany.
Volker LauxBayer AG, Wuppertal, Germany.ORCID 0000-0003-0891-3683
Stefan HeitmeierBayer AG, Wuppertal, Germany.
Stavros V KonstantinidesCenter for Thrombosis and Hemostasis (CTH), and.
Thomas MünzelCenter for Thrombosis and Hemostasis (CTH), and.
Miguel A Andrade-NavarroInstitute of Organismic and Molecular Evolution, Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0001-6650-1711
Kirsten LeineweberBayer AG, Wuppertal, Germany.
Philipp S WildPreventive Cardiology and Preventive Medicine, Center for Cardiology.
Johannes Gutenberg University Mainz · DEBayer (Germany) · DECardio-Pulmonary Institute · DEDemocritus University of Thrace · GRMünchen Klinik Bogenhausen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with isolated pulmonary embolism (PE) have a distinct clinical profile from those with deep vein thrombosis (DVT)-associated PE, with more pulmonary conditions and atherosclerosis. These findings suggest a distinct molecular pathophysiology and the potential involvement of alternative pathways in isolated PE. To test this hypothesis, data from 532 individuals from the Genotyping and Molecular Phenotyping of Venous ThromboEmbolism Project, a multicenter prospective cohort study with extensive biobanking, were analyzed. Targeted, high-throughput proteomics, machine learning, and bioinformatic methods were applied to contrast the acute-phase plasma proteomes of isolated PE patients (n = 96) against those of patients with DVT-associated PE (n = 276) or isolated DVT (n = 160). This resulted in the identification of shared molecular processes between PE phenotypes, as well as an isolated PE-specific protein signature. Shared processes included upregulation of inflammation, response to oxidative stress, and the loss of pulmonary surfactant. The isolated PE-specific signature consisted of 5 proteins: interferon-γ, glial cell line-derived neurotrophic growth factor, polypeptide N-acetylgalactosaminyltransferase 3, peptidyl arginine deiminase type-2, and interleukin-15 receptor subunit α. These proteins were orthogonally validated using cis protein quantitative trait loci. External replication in an independent population-based cohort (n = 5778) further validated the proteomic results and showed that they were prognostic for incident primary isolated PE in individuals without history of VTE (median time to event: 2.9 years; interquartile range: 1.6-4.2 years), supporting their possible involvement in the early pathogenesis. This study has identified molecular overlaps and differences between VTE phenotypes. In particular, the results implicate noncanonical pathways more commonly associated with respiratory and atherosclerotic disease in the acute pathophysiology of isolated PE.

Indexed as

ProteomeTranscriptomeAcute-Phase ProteinsAdultAgedAtherosclerosisComorbidityDatasets as TopicFemaleFollow-Up StudiesGene Expression RegulationGlial Cell Line-Derived Neurotrophic FactorHumansInterferon-gammaInterleukin-15 Receptor alpha SubunitMachine LearningAcute-Phase ProteinsGDNF protein, humanGlial Cell Line-Derived Neurotrophic FactorInterferon-gammaInterleukin-15 Receptor alpha SubunitN-AcetylgalactosaminyltransferasesPADI2 protein, humanPolypeptide N-acetylgalactosaminyltransferaseProtein-Arginine Deiminase Type 2ProteomePulmonary Surfactants

Identifiers

PMID33529319
PMCPMC9635523
OpenAlexW3127352884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.